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    Materials: 
 385 samples of M. tuberculosis from new TB cases were collected from different 
regions of Kazakhstan. 
 
     Methods: 
 Clinical isolates of M. tuberculosis were collected from regional TB centers and 
deposited at the Reference laboratory of the National Scientific Center for 
Tuberculosis Problems (Almaty);  
 
 After primary isolation mycobacteria were subcultured on solid Lowenstein-
Jensen medium; 
 
  Drug susceptibility testing for M. tuberculosis  was performed using absolute 
concentration method; 
 
 Heat inactivated mycobacterial colonies that were incubated at 950С during 45 
minutes were used for MIRU-VNTR typing; 
 
 Genotyping of clinical isolates of M. tuberculosis was carried out by 15 MIRU-
VNTR method (Figure 3); 
 




Figure 2. Incidence of MDR tuberculosis in 
Kazakhstan  
 
 Tuberculosis (TB) remains a major health 
problem in Kazakhstan. Despite of that the 
rates of TB disease and mortality decreased 
from 58,5/100000 and 4,1/100000 in 2015 to 
52,7/100000 and 3,4/100000 in 2016 
respectively, the rate of multidrug-resistant 
TB (MDR-TB) increased from 12,2/100000 
in 2014 to 13,5/100000 in 2015 [1];    
 
 MDR strains associated with resistance to 
the main two first line anti-TB drugs – 
isoniazid and rifampicin are the most 
dangerous. 27 countries relate to high 
MDR-TB burden countries, 15 of them in 
the European region, including 
Kazakhstan [2]; 
 
 Methods of genotyping of M. tuberculosis 
play important role in TB infection control. 
There are more than 10 methods of 
genotyping, MIRU-VNTR is one of the widely 
used method in the world.  
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Figure 3. MIRU-VNTR typing  
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 Estimation of biological diversity of M. tuberculosis clinical isolates among new TB 
cases in Kazakhstan by MIRU-VNTR analysis. 
№ MIRU-VNTR profile Isolate 
1 225 425 173 533 56 
2 225 313 153 323 43 
3 224 325 172 324 30 
Phylogenetic tree construction by 
UPGMA method  
 Phylogenic tree for 385 M. tuberculosis clinical isolates  was built using www.miru-
vntr.org web-resource based on the results of MIRU-VNTR analysis using UPGMA 
(Unweighted pair-group method using arithmetic averages) method (Figure 4). 
 
  Beijing family strains associated with drug resistance to anti-TB drugs prevail 
among new TB cases in Kazakhstan. Strains of Beijing genotype were found in 
63,1% cases (Figure 5 and Table 1).  
 
 The second meaningful genotype that is spread in the territory of Kazakhstan 
among new TB cases is LAM, the frequency of distribution is 10,6%.  
 
 Strains of URAL and X families were detected almost with the same frequency – 
8.6% and 8.1%, respectively.  
 
 Other genotypes (CAS, Cameroon, Uganda, NEW-1, Ghana) were identified in 
less than 2.1% cases. 
Figure 4. Genotyping of  MDR-TB by 
15 MIRU-VNTR  
 Prevalence of Beijing family strains among new TB cases in Kazakhstan was 
shown (83,1%). 
 
  We identified that Beijing genotype is responsible for ongoing TB transmission in 
Kazakhstan in the present time.  
 
 This genotype is associated with drug resistance and currently distributed in the 
former USSR countries and countries of Eastern Europe. 
 
 According to publications [3-5] the genotype is more virulent, that is why 
investigation of epidemiology of Beijing genotype plays crucial role in TB 
monitoring. 
Figure 5. Genotypes of clinical isolates of M. 
tuberculosis among new TB cases 
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Table 1. Genotypes of M. tuberculosis clinical isolates 
M. tuberculosis genotypes  Number of isolates % 
Beijing 243 63.1 
LAM 41 10.6 
URAL 33 8.6 
X 31 8.1 
Haarlem 25 6.5 
NEW-1 8 2.1 
CAS 1 0.25 
Cameroon 1 0.25 
Uganda 1 0.25 
Ghana 1 0.25 









Figure 1. TB incidence and TB mortality in 
Kazakhstan  
